Rationale for the EUCAST clinical breakpoints

First Page		Document Content
Date: 2012-06-06 13:49:57 Biology Piperazines Lactams Triazoles Fungal diseases Itraconazole Posaconazole Aspergillus fumigatus Aspergillus Chemistry Organic chemistry Antifungals		Rationale for the EUCAST clinical breakpoints Add to Reading List Source URL: www.eucast.org Download Document from Source Website File Size: 208,02 KB Share Document on Facebook

	TM POSACONAZOLE ASSAY FOR THE ROCHE/HITACHI 917 AUTOMATED CLINICAL CHEMISTRY ANALYZER S. Oh, B. Moon, J. Valdez ARK Diagnostics Inc., Fremont, CA DocID: 1u5Le - View Document
	NIH Public Access Author Manuscript Fungal Biol. Author manuscript; available in PMC 2012 December 1. NIH-PA Author Manuscript DocID: 1pA4i - View Document
	Highlights from the 5th Trends in Medical Mycology (TIMM) congress Valencia, Spain, 2-5 October 2011 Jenny Bryan, medical writer, London Invasive fungal disease: “know your enemy, know your goal!” Rising numbers of i DocID: 1odTa - View Document
	Report from the 38th annual meeting of the European Group for Blood and Marrow Transplantation, Geneva, Switzerland, April 1-4, 2012 Joanna Lumb, medical writer, London, UK Unmet needs in managing invasive fungal inf DocID: 1nM01 - View Document
	Invasive Fungal Disease highlighted at the 22nd European Congress of Clinical Microbiology and Infectious Diseases, London, UK, 31 March – 3 April 2012 Jenny Bryan, London, UK Antimicrobial stewardship is key in fight DocID: 1nzYJ - View Document